Related Experiment Video
Updated: Oct 26, 2025
09:42
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
13.7K
Multidimensional factors affecting medication adherence among patients with chronic obstructive pulmonary disease
Goncagul Aldan1, Aylin Helvaci2, Leyla Ozdemir2
1Faculty of Health Sciences, Nursing Department, Yüksek İhtisas University, Ankara, Turkey.
Journal of Clinical Nursing
|July 26, 2021
Summary
Patient, treatment, and condition factors significantly impact medication adherence in chronic obstructive pulmonary disease (COPD). Improving adherence requires targeted interventions for high-risk COPD patients.
Area of Science:
- Pulmonary Medicine
- Health Outcomes Research
Background:
- Medication adherence is critical for managing chronic diseases like COPD.
- The World Health Organization's Multidimensional Adherence Model (MAM) identifies numerous influencing factors.
- Understanding these factors is key to improving patient outcomes.
Purpose of the Study:
- To investigate the impact of socioeconomic, patient, treatment, condition, and health system factors on medication adherence in COPD patients.
- To identify key drivers of medication adherence in this population.
Main Methods:
- A descriptive correlational study involving 114 COPD patients.
- Data collected across five MAM dimensions, assessing adherence (ARMS-7), self-efficacy (CSES), and symptoms (CAT).
- Statistical analyses included descriptive, correlational, and structural equation modeling.
Main Results:
- Patient-related factors like BMI, smoking history, and self-efficacy were associated with adherence.
- Treatment-related factors such as COPD diagnosis duration and number of medications correlated with adherence.
- Condition-related factors, specifically the presence of comorbid illnesses, also influenced medication adherence.
Conclusions:
- Medication adherence in COPD is primarily influenced by patient, treatment, and condition-specific factors.
- Interventions should focus on newly diagnosed patients, those with multiple comorbidities or medications, and those with low self-efficacy.
- Healthcare professionals should develop targeted training and counseling programs to enhance adherence.
More Related Videos
Related Concept Videos
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.5K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.5K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.8K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.6K
01:26COPD: Management Using Bronchodilators and Corticosteroids
494
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
494
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
157
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
157